ZOVIRAX oral formulations are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes.
ZOVIRAX oral formulations are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients.
ZOVIRAX oral formulations are indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.
ZOVIRAX oral formulations are indicated for the treatment of varicella infections (chicken-pox) and herpes zoster (shingles).